Intracellular gonadotropin-releasing hormone immunoreactivity in gonadotrophs of intact or castrated male rats: semiquantitative estimation of testosterone and GnRH antagonist treatment.
Changes in intracellular gonadotropin-releasing hormone (GnRH) immunoreactivity (GnRH-IR) in pituitary gonadotrophs were assessed by the use of a semiquantitative immunocytochemical method in male rats undergoing various manipulations known to greatly modify gonadotropin secretion. In basal conditions, immunoreactive GnRH was localized in the cytoplasmic matrix, the secretory granules and the nucleus of these cells. Following intravenous stimulation with GnRH (100 ng i.v.), the GnRH-IR increased rapidly in all these three subcellular compartments, peaking at 15 min. In untreated, long-term castrated rats, GnRH-IR increased both in the basal state and after administration of GnRH. Injection of the castrated rats with testosterone propionate reduced the observed GnRH-IR to the level observed in intact rats. Acute or chronic treatment of castrated rats with a potent GnRH antagonist rendered GnRH-IR completely undetectable in all the three previously positive subcellular compartments of gonadotrophs, and GnRH-IR did not reappear after stimulation with GnRH. In sum, the fact that modifications of GnRH immunoreactivity are observed in rat gonadotrophs: (1) confirms the GnRH internalization process; (2) suggests different sites of action for GnRH within the cell, and (3) demonstrates rapid clearance of intracellular GnRH after stimulation.
Morel
G
G
CNRS URA 1454, School of Medicine Lyon-Sud, Oullins, France.
Aubert
M L
ML
Dubois
P M
PM
D000818:Animals; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D009919:Orchiectomy; D010902:Pituitary Gland / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013739:Testosterone / Q000494:pharmacology
D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone